Squarepoint Ops LLC Scynexis Inc Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.4 - $2.77 $142,353 - $281,656	-101,681 Reduced 68.02%	47,798 $95,000
Q1 2024 May 15, 2024	BUY	$1.39 - $2.21 $166,681 - $265,012	119,915 Added 405.61%	149,479 $219,000
Q4 2023 Feb 14, 2024	BUY	$1.56 - $2.24 $46,119 - $66,223	29,564 New	29,564 $65,000
Q2 2021 Aug 16, 2021	SELL	$6.5 - $9.97 $662,207 - $1.02 Million	-101,878 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.93 - $9.63 $706,014 - $981,085	101,878 New	101,878 $809,000

13.7M

21.9K

2.6K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $38.5M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.